Showing results (31-40 of 80) with videos related to
Sort By:
Pageof 8
Current Treatment Options in Cardiovascular Medicine|November 11, 2010
Mechanical circulatory support for advanced heart failureChetan B Patel, Kevin M Alexander, Joseph G RogersBiomedical Physics & Engineering Express|August 21, 2025
Development of a radiochromic film dosimetry readout systemKevin M Alexander, Timothy Olding, L John John SchreinerJournal of the American College of Cardiology|September 17, 2016
AL (Light-Chain) Cardiac Amyloidosis: A Review of Diagnosis and TherapyRodney H Falk, Kevin M Alexander, Ronglih Liao, et al.Heart Failure Reviews|July 1, 2026
Overcoming barriers to early diagnosis and treatment of p.Val142Ile amyloid transthyretin (ATTR) cardiomyopathyKeith C Ferdinand, Senthil Selvaraj, Kevin M Alexander, et al.The Journal of Heart and Lung Transplantation : the Official Publication of the International Society for Heart Transplantation|February 8, 2017
Angiotensin II antagonism is associated with reduced risk for gastrointestinal bleeding caused by arteriovenous malformations in patients with left ventricular assist devicesBrian A Houston, Andrea L C Schneider, Joban Vaishnav, et al.ESC Heart Failure|December 25, 2021
Heart transplantation strategies in arrhythmogenic right ventricular cardiomyopathy: a tertiary ARVC centre experiencePaul J Scheel, Katherine Giuliano, Crystal Tichnell, et al.Cardiology and Therapy|July 12, 2026
Defining Heart Failure Endpoint in ATTR Amyloidosis Clinical Trials: Time for an Update?Diona Gjermeni, Kevin M Alexander, James L Januzzi, et al.Research Square|June 22, 2026
Development of Human iPSC-based Microphysiogical Models of Transthyretin Amyloid CardiomyopathyMarcus A C Williams, Junseong Park, Atharva R Mulay, et al.Cardiology and Therapy|July 19, 2025
Current and Future Treatment Landscape of Transthyretin Amyloid CardiomyopathyEmily Margolin, Lily K Stern, Alessia Argiro, et al.Heart Rhythm O2|April 1, 2024
Outcomes with guideline-directed medical therapy and cardiac implantable electronic device therapies for patients with heart failure with reduced ejection fractionJohn L Mignone, Kevin M Alexander, Michael Dobbles, et al.Pageof 8